Helicobacter pylori therapy 1 (Biotie)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHelicobacter pylori therapy 1 (Biotie)
Drug Alias NameHelicobacter pylori therapy (Contral Pharma)
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotie Therapies Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotie Therapies Corp
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A